R. Kawai

611 total citations
25 papers, 516 citations indexed

About

R. Kawai is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, R. Kawai has authored 25 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in R. Kawai's work include Drug Transport and Resistance Mechanisms (6 papers), Neuroscience and Neuropharmacology Research (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). R. Kawai is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Neuroscience and Neuropharmacology Research (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). R. Kawai collaborates with scholars based in Japan, United States and Switzerland. R. Kawai's co-authors include Chiaki Tanaka, Malcolm Rowland, Kenju Otsuka, Soo‐Chang Song, Yuichi Sugiyama, Hajime Suzuki, Ronald G. Blasberg, Amy Hauck Newman, Kenner C. Rice and Hiroshi Yamazaki and has published in prestigious journals such as Journal of Controlled Release, Antimicrobial Agents and Chemotherapy and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

R. Kawai

25 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Kawai Japan 11 161 130 126 88 67 25 516
Donald Heald United States 20 351 2.2× 252 1.9× 102 0.8× 100 1.1× 46 0.7× 36 917
Jia Yu China 17 89 0.6× 191 1.5× 35 0.3× 20 0.2× 29 0.4× 58 755
Weiming Ruan United States 11 81 0.5× 296 2.3× 54 0.4× 19 0.2× 19 0.3× 13 696
F. G. Zaki United States 15 244 1.5× 344 2.6× 100 0.8× 42 0.5× 8 0.1× 31 1.0k
Guolin Zhao China 18 68 0.4× 403 3.1× 74 0.6× 12 0.1× 184 2.7× 35 895
Suhong Yu China 16 217 1.3× 382 2.9× 43 0.3× 16 0.2× 12 0.2× 31 773
Ibtissam Echchgadda United States 15 275 1.7× 199 1.5× 196 1.6× 68 0.8× 111 1.7× 36 775
Robert O’Donnell United States 12 109 0.7× 209 1.6× 14 0.1× 10 0.1× 58 0.9× 29 709
Achim Sauer Germany 14 162 1.0× 369 2.8× 39 0.3× 43 0.5× 10 0.1× 30 1.1k
Darcy R. Flora United States 10 70 0.4× 254 2.0× 73 0.6× 18 0.2× 30 0.4× 27 746

Countries citing papers authored by R. Kawai

Since Specialization
Citations

This map shows the geographic impact of R. Kawai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Kawai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Kawai more than expected).

Fields of papers citing papers by R. Kawai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Kawai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Kawai. The network helps show where R. Kawai may publish in the future.

Co-authorship network of co-authors of R. Kawai

This figure shows the co-authorship network connecting the top 25 collaborators of R. Kawai. A scholar is included among the top collaborators of R. Kawai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Kawai. R. Kawai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Reilly, Terence, Paul M.J. McSheehy, R. Kawai, et al.. (2009). Comparative pharmacokinetics of RAD001 (everolimus) in normal and tumor-bearing rodents. Cancer Chemotherapy and Pharmacology. 65(4). 625–639. 55 indexed citations
2.
Yamazaki, Hiroshi, et al.. (2009). Deactivation of anti-cancer drug letrozole to a carbinol metabolite by polymorphic cytochrome P450 2A6 in human liver microsomes. Xenobiotica. 39(11). 795–802. 44 indexed citations
3.
Kawai, R., et al.. (2004). Chaos synchronization in a mutually coupled laser array subjected to self-mixing modulation. Journal of Optics B Quantum and Semiclassical Optics. 6(7). R19–R32. 1 indexed citations
4.
Comets, Emmanuelle, France Mentré, Fritz Nimmerfall, et al.. (1999). Nonparametric analysis of the absorption profile of octreotide in rabbits from long-acting release formulation OncoLAR. Journal of Controlled Release. 59(2). 197–205. 11 indexed citations
6.
Song, Soo‐Chang, Hajime Suzuki, R. Kawai, & Yuichi Sugiyama. (1999). Effect of PSC 833, a P-Glycoprotein Modulator, on the Disposition of Vincristine and Digoxin in Rats. Drug Metabolism and Disposition. 27(6). 689–694. 67 indexed citations
7.
Chiba, Kōji, et al.. (1999). PHARMACODYNAMICS OF FTY 720 IN RATS. Transplantation. 67(7). S62–S62. 1 indexed citations
8.
Kawai, R., et al.. (1998). Physiologically Based Pharmacokinetics of Cyclosporine A: Extension to Tissue Distribution Kinetics in Rats and Scale-up to Human. Journal of Pharmacology and Experimental Therapeutics. 287(2). 457–468. 123 indexed citations
9.
Song, Soo‐Chang, et al.. (1998). Dose-dependent effects of PSC 833 on its tissue distribution and on the biliary excretion of endogenous substrates in rats.. PubMed. 26(11). 1128–33. 13 indexed citations
10.
Kawai, R., et al.. (1994). Kinetic analysis of rat exocrine gland muscarinic receptors in vivo.. Journal of Pharmacology and Experimental Therapeutics. 269(3). 1205–1212. 2 indexed citations
11.
Bruelisauer, Armin, et al.. (1994). Absorption and disposition of SDZ IMM 125, a new cyclosporine derivative, in rats after single and repeated administration.. Drug Metabolism and Disposition. 22(2). 194–199. 6 indexed citations
12.
Kawai, R., et al.. (1991). Regional Brain Measurement ofBmaxandKDwith the Opiate Antagonist Cyclofoxy: Equilibrium Studies in the Conscious Rat. Journal of Cerebral Blood Flow & Metabolism. 11(4). 529–544. 40 indexed citations
13.
Kawai, R., Yuki Sawada, Michael A. Channing, et al.. (1990). BBB transport and rapid tissue binding of cyclofoxy: comparison of active and inactive enantiomers. American Journal of Physiology-Heart and Circulatory Physiology. 259(4). H1278–H1287. 5 indexed citations
14.
Kawai, R., Yuki Sawada, Michael A. Channing, et al.. (1990). Kinetic analysis of the opiate antagonist cyclofoxy in rat brain: simultaneous infusion of active and inactive enantiomers.. Journal of Pharmacology and Experimental Therapeutics. 255(2). 826–835. 17 indexed citations
15.
Kamimura, Hidetaka, et al.. (1988). Metabolic fate of indeloxazine hydrochloride: α-glucoside formation in rats. Xenobiotica. 18(2). 141–149. 13 indexed citations
16.
Kamimura, Hidetaka, et al.. (1987). Disposition and metabolism of indeloxazine hydrochloride, a cerebral activator, in rats. Xenobiotica. 17(6). 645–658. 8 indexed citations
17.
Kawai, R., S. Fujita, & Takahito Suzuki. (1986). A new lidocaine metabolite, omega-diethylamino-2-hydroxymethyl-6-methylacetanilide.. Drug Metabolism and Disposition. 14(2). 277–279. 11 indexed citations
18.
Enjoji, Yoshihisa, et al.. (1983). Metabolic fate of [14C]SM-1652, a new antipseudomonal cephalosporin, after parenteral administration to rats. Antimicrobial Agents and Chemotherapy. 24(1). 42–47. 1 indexed citations
19.
Iwatsubo, T., et al.. (1973). Vibrations of asymmetric rotors supported by asymmetric bearings. Archive of Applied Mechanics. 42(6). 416–432. 10 indexed citations
20.
Iwatsubo, T., H. Kanki, & R. Kawai. (1972). Vibration of Asymmetric Rotor through Critical Speed with Limited Power Supply. Journal of Mechanical Engineering Science. 14(3). 184–194. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026